PAHC: Phibro Animal Health Corporation Stock

by  •  • Comments Off on PAHC: Phibro Animal Health Corporation Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 462.48
Enterprise Value ($M) 1,149.83
Book Value ($M) 246.80
Book Value / Share 12.14
Price / Book 1.87
NCAV ($M) -292.55
NCAV / Share -14.38
Price / NCAV -1.58

Profitability (mra)
Return on Invested Capital (ROIC) 0.02
Return on Assets (ROA) 0.02
Return on Equity (ROE) 0.07

Liquidity (mrq)
Quick Ratio 1.37
Current Ratio 3.20

Balance Sheet (mrq) ($M)
Current Assets 746.15
Assets 1,285.51
Liabilities 1,038.71
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1,017.68
Operating Income 59.34
Net Income 2.42
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 87.59
Cash from Investing -48.19
Cash from Financing -6.77

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Brandes Investment Partners, Lp 10.48 43.53
11-15 13D/A BFI Co., LLC 49.90 0.00
11-12 13G/A Vanguard Group Inc 7.34 0.00
10-16 13G Pzena Investment Management Llc 7.20 -26.58

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-03 136,742 445,511 30.69
2025-02-28 50,080 270,361 18.52
2025-02-27 39,606 170,406 23.24
2025-02-26 84,165 203,190 41.42

(click for more detail)

Similar Companies
OCUL – Ocular Therapeutix, Inc. OKUR – OnKure Therapeutics, Inc.
OMER – Omeros Corporation PTGX – Protagonist Therapeutics, Inc.
QTTB – Q32 Bio Inc.


Financial data and stock pages provided by
Fintel.io